Viewing Study NCT00004050


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2025-12-28 @ 4:13 PM
Study NCT ID: NCT00004050
Status: TERMINATED
Last Update Posted: 2014-07-29
First Post: 1999-12-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
Sponsor: Vical
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module